MEILLEURE HEALTH INTERNATIONAL INDUSTRY GROUP LIMITED

Meilleure Health International Industry Group Limited

2327

BMG5975D1048

Construction Materials

Market Closed - Hong Kong S.E. Other stock markets 04:08:12 2024-06-17 EDT			5-day change	1st Jan Change
0.196 ^HKD	+4.81%		+10.73%	-20.33%

05-02	Meilleure Health's 2023 Profit, Revenue Rise	MT
04-10	Meilleure Health International Industry Group Limited Announces Board and Committees Changes	CI

Jiwa Bio-Pharm Holdings Ltd. Announces Resignation of Yue Pui Kwan as Company Secretary and Alternate Authorised Representative

March 25, 2013 at 05:37 am

The board of directors of Jiwa Bio-Pharm Holdings Limited announced that Ms. Yue Pui Kwan will resign as the Company Secretary and Alternate Authorised Representative of the company with effect from 27 March 2013. The company will announce new appointment of the Company Secretary and Alternate Authorised Representative as soon as the office is filled.

Latest news about Meilleure Health International Industry Group Limited

Meilleure Health's 2023 Profit, Revenue Rise	05-02	MT
Meilleure Health International Industry Group Limited Announces Board and Committees Changes	04-10	CI
Meilleure Health International Industry Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 20 August 2024	03-28	CI
Meilleure Health International Industry Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Meilleure Health International Industry Group Limited Provides Preliminary Consolidated Earnings Guidance for the Year Ended 31 December 2023	03-22	CI
Meilleure Health Sells 661,408 Shares of Hanshang Group	01-10	MT
Meilleure Health to Extend 200 Million Yuan Revolving Loan Facility to Affiliate	11-28	MT
Meilleure Health to Buy 3 Properties from Affiliate	23-10-17	MT
Meilleure Health International Industry Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Meilleure Health International Industry's Profit to Rise in H1	23-08-14	MT
Meilleure Health International Industry Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2023	23-08-11	CI
Meilleure Health International Industry Group Limited commences an Equity Buyback Plan for 409,375,663 shares, representing 10% of its issued share capital, under the authorization approved on June 27, 2023.	23-07-25	CI
Meilleure Health Further Disposes of Hanshang Shares for HK$7.1 Million	23-07-11	MT
Meilleure Health Sells 1.4 Million Shares in Hanshang Group	23-07-06	MT
Jiangsu Guangyu Zhaoneng New Energy Technology Co., Ltd. announced that it has received CNY 140 million in funding from a group of investors	23-07-05	CI
Meilleure Health International Industry Group Limited Approves Final Dividend of the Financial Year Ended 31 December 2022	23-06-27	CI
Meilleure Health International Industry Group Limited's Equity Buyback announced on June 27, 2022, has expired.	23-06-26	CI
Meilleure Health International Industry Group Limited Announces Board Changes	23-04-11	CI
Meilleure Health's 2022 Attributable Profit Plunges; Shares Down 4%	23-03-31	MT
Meilleure Health International Industry Group Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 22 August 2023	23-03-30	CI
Meilleure Health International Industry Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Meilleure Health Forecasts Plunge in FY22 Profit	23-03-15	MT
Meilleure Health Posts Profit Drop for First Half	22-09-26	MT
Meilleure Health International Industry Group Limited(SEHK:2327) dropped from S&P Global BMI Index	22-09-19	CI
Meilleure Health International Industry Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI

Chart Meilleure Health International Industry Group Limited

Duration

Period

Chart Meilleure Health International Industry Group Limited

More charts

Company Profile

Meilleure Health International Industry Group Limited is an investment holding company principally engaged in the trading of health care products, chemical materials and building materials. The Company operates its business through five segments. The Trading of Health Care Products, Chemical Materials and Building Materials segment is engaged in the trading of health care products, chemical materials and building materials. The Research and Development segment is engaged in the research and development of chemical and biological products. The Investment and Treasury Function segment is engaged in investment holding and treasury function. The Consultancy and Agency Business segment is engaged in the provision of property agency and consultancy service. The Property Development segment is engaged in the development of residential properties.

Sector

Construction Materials

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Construction Material Wholesale

	1st Jan change	Capi.
MEILLEURE HEALTH INTERNATIONAL INDUSTRY GROUP LIMITED	-20.33%	97.97M
BORAL LIMITED	+8.16%	4.17B
THAIHOLDINGS	-0.28%	532M
COMPLETE LOGISTIC SERVICES	-18.94%	497M
SHENZHEN HUAKONG SEG CO., LTD.	-17.80%	404M
ISRAEL SHIPYARDS INDUSTRIES LTD	-23.29%	385M
KUWAIT PORTLAND CEMENT CO. K.P.S.C.	+4.88%	287M
PAN-UNITED CORPORATION LTD	+22.37%	239M
ADVAN GROUP CO., LTD.	-10.91%	218M
NSL LTD	-9.43%	199M

Construction Material Wholesale

Meilleure Health International Industry Group Limited

Equities

2327

BMG5975D1048

Construction Materials

Jiwa Bio-Pharm Holdings Ltd. Announces Resignation of Yue Pui Kwan as Company Secretary and Alternate Authorised Representative

Latest news about Meilleure Health International Industry Group Limited

Chart Meilleure Health International Industry Group Limited

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Construction Material Wholesale